Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of SEK 14.87 billion. The enterprise value is 15.57 billion.

Market Cap	14.87B
Enterprise Value	15.57B

Important Dates

The next confirmed earnings date is Thursday, July 16, 2026.

Earnings Date	Jul 16, 2026
Ex-Dividend Date	May 6, 2026

Share Statistics

Vitrolife AB has 135.42 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class	135.42M
Shares Outstanding	135.42M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	61.98%
Float	73.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	23.97
PS Ratio	4.37
PB Ratio	1.84
P/TBV Ratio	n/a
P/FCF Ratio	26.65
P/OCF Ratio	20.15
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.85, with an EV/FCF ratio of 27.90.

EV / Earnings	-3.11
EV / Sales	4.57
EV / EBITDA	15.85
EV / EBIT	27.17
EV / FCF	27.90

Financial Position

The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.20.

Current Ratio	3.68
Quick Ratio	2.83
Debt / Equity	0.20
Debt / EBITDA	1.61
Debt / FCF	2.84
Interest Coverage	9.10

Financial Efficiency

Return on equity (ROE) is -47.27% and return on invested capital (ROIC) is 6.56%.

Return on Equity (ROE)	-47.27%
Return on Assets (ROA)	2.57%
Return on Invested Capital (ROIC)	6.56%
Return on Capital Employed (ROCE)	5.38%
Weighted Average Cost of Capital (WACC)	12.90%
Revenue Per Employee	3.02M
Profits Per Employee	-4.45M
Employee Count	1,151
Asset Turnover	0.24
Inventory Turnover	3.35

Taxes

In the past 12 months, Vitrolife AB has paid 115.00 million in taxes.

Income Tax	115.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.80% in the last 52 weeks. The beta is 1.76, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.76
52-Week Price Change	-26.80%
50-Day Moving Average	96.27
200-Day Moving Average	125.13
Relative Strength Index (RSI)	58.54
Average Volume (20 Days)	287,019

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of SEK 3.41 billion and -5.01 billion in losses. Loss per share was -37.01.

Revenue	3.41B
Gross Profit	2.00B
Operating Income	573.00M
Pretax Income	-4.90B
Net Income	-5.01B
EBITDA	936.00M
EBIT	573.00M
Loss Per Share	-37.01

Full Income Statement

Balance Sheet

The company has 886.00 million in cash and 1.58 billion in debt, giving a net cash position of -696.00 million or -5.14 per share.

Cash & Cash Equivalents	886.00M
Total Debt	1.58B
Net Cash	-696.00M
Net Cash Per Share	-5.14
Equity (Book Value)	8.07B
Book Value Per Share	59.58
Working Capital	1.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 738.00 million and capital expenditures -180.00 million, giving a free cash flow of 558.00 million.

Operating Cash Flow	738.00M
Capital Expenditures	-180.00M
Depreciation & Amortization	353.00M
Net Borrowing	-424.00M
Free Cash Flow	558.00M
FCF Per Share	4.12

Full Cash Flow Statement

Margins

Gross margin is 58.65%, with operating and profit margins of 16.83% and -147.17%.

Gross Margin	58.65%
Operating Margin	16.83%
Pretax Margin	-143.76%
Profit Margin	-147.17%
EBITDA Margin	27.49%
EBIT Margin	16.83%
FCF Margin	16.39%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.97%.

Dividend Per Share	1.10
Dividend Yield	0.97%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	0.08%
Shareholder Yield	1.02%
Earnings Yield	-33.70%
FCF Yield	3.75%

Dividend Details

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 3.23 and a Piotroski F-Score of 5.

Altman Z-Score	3.23
Piotroski F-Score	5